Neurohormonal modulation: The new paradigm of pharmacological treatment of heart failure

Neurohormonal modulation: The new paradigm of pharmacological treatment of heart failure

Show other versions (1)

The current paradigm of medical therapy for heart failure with reduced ejection fraction (HFrEF) is triple neurohormonal blockade with an angiotensin-converting enzyme inhibitor (ACEI), a beta-blocker (BB) and a mineralocorticoid receptor antagonist (MRA). However, three-year mortality remains over...

Full description

Bibliographic Details
Main Authors: J. Silva-Cardoso, D. Brás, F. Canário-Almeida, A. Andrade, L. Oliveira, F. Pádua, C. Fonseca, N. Bragança, S. Carvalho, R. Soares, J. Ferreira Santos
Format: Article
Language:English
Published: Elsevier 2019-03-01
Series:Revista Portuguesa de Cardiologia
Online Access:http://www.sciencedirect.com/science/article/pii/S0870255118300635

Internet

http://www.sciencedirect.com/science/article/pii/S0870255118300635

Similar Items